Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Infection and Immunity

• Publication date

  1999-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/IAI.67.8.4064-4071.1999PMID 10417175PMCID PMC96703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Observer Bias in Acellular Pertussis Vaccine Trials

  1999cited by this paper
• Observer Bias in Acellular Pertussis Vaccine Trials

  1999cited by this paper
• Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population.

  1998cited by this paper
• A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis

  1998cited by this paper
• Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children

  1998influential reference
• Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

  1998cited by this paper
• Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co‐stimulatory molecule CD28

  1998cited by this paper
• Bordetella parapertussis Infection in Children: Epidemiology, Clinical Symptoms, and Molecular Characteristics of Isolates

  1998cited by this paper
• A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.

  1998cited by this paper
• Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28.

  1998cited by this paper
• Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

  1998cited by this paper
• Cytokine mRNA Expression and Proliferative Responses Induced by Pertussis Toxin, Filamentous Hemagglutinin, and Pertactin ofBordetella pertussis in the Peripheral Blood Mononuclear Cells of Infected and Immunized Schoolchildren and Adults

  1998influential reference
• Prevalence of markers of exposure to Bordetella pertussis among Italian young adults.

  1998cited by this paper
• Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.

  1998cited by this paper
• Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.

  1998cited by this paper
• Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children.

  1998cited by this paper
• ESEN : a comparison of vaccination programmes Part two : pertussis.

  1998influential reference
• Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials.

  1997cited by this paper
• Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.

  1997cited by this paper
• Cell-mediated and Antibody Responses to Bordetella pertussis Antigens in Children Vaccinated With Acellular or Whole-cell Pertussis Vaccines

  1997cited by this paper
• Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells.

  1997cited by this paper
• Pertussis: current concepts of pathogenesis and prevention.

  1997cited by this paper
• Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes

  1997cited by this paper
• Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines

  1997cited by this paper
• Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.

  1997cited by this paper
• Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine

  1996influential reference
• Secretion of IFN-gamma, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation.

  1996cited by this paper
• A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

  1996cited by this paper
• Comparison of 13 acellular pertussis vaccines: overview and serologic response.

  1995cited by this paper
• Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.

  1995cited by this paper
• Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity

  1993cited by this paper
• Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans

  1993cited by this paper
• Pertussis and the pertussis vaccines

  1993cited by this paper
• Pertussis antibodies, protection, and vaccine efficacy after household exposure.

  1992cited by this paper
• Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis

  1992cited by this paper
• Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.

  1988cited by this paper
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN?PROTECIVE EFFICACY AND ADVERSE EVENTS

  1988cited by this paper
• Characterization of fimbrial subunits from Bordetella species.

  1987cited by this paper
• Population genetics of pathogenic bacteria.

  1987cited by this paper
• NEUROLOGICAL EXAMINATION

  1957cited by this paper

• "Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model".

  2023cites this paper
• Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines

  2021cites this paper
• Maternal Immunization: Nature Meets Nurture

  2020cites this paper
• Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model

  2020cites this paper
• Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies

  2019cites this paper
• Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

  2019cites this paper
• Human Immune Responses to Pertussis Vaccines.

  2019cites this paper
• Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant

  2019cites this paper
• Pertussis Vaccines and Vaccination Strategies. An Ever-Challenging Health Problem.

  2019cites this paper
• PERISCOPE: road towards effective control of pertussis.

  2019cites this paper
• A cell-based assay for the safety testing of pertussis-containing vaccines

  2018cites this paper
• Immunological considerations regarding parental concerns on pediatric immunizations.

  2017cites this paper
• Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.

  2017cites this paper
• Long time immunogenicity of measles vaccine in the vaccination era: An open question

  2017cites this paper
• Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults

  2016influential citation
• Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination.

  2016cites this paper
• Vaccine-induced protective immunity to Bordetella pertussis

  2016cites this paper
• Rediscovering Pertussis

  2016cites this paper
• Roads to the development of improved pertussis vaccines paved by immunology

  2015cites this paper
• Waning and aging of cellular immunity to Bordetella pertussis.

  2015cites this paper
• T-cell immune responses to Bordetella pertussis infection and vaccination.

  2015influential citation
• Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

  2015cites this paper
• Characterization of co-purified acellular pertussis vaccines

  2015cites this paper
• Prediction of Virulence Factors Using Bioinformatics Approaches

  2014cites this paper
• Immune Responses to Pertussis Antigens in Infants and Toddlers after Immunization with Multicomponent Acellular Pertussis Vaccine

  2014cites this paper
• Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity

  2014cites this paper
• Do we need a new vaccine to control the re-emergence of pertussis?

  2014cites this paper
• Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?

  2014cites this paper
• Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

  2013cites this paper
• Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.

  2013cites this paper
• Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

  2013cites this paper
• Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults.

  2013cites this paper
• Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.

  2013cites this paper
• Réponses immunitaires du grand prématuré à la vaccination contre la coqueluche

  2013cites this paper
• Resurgence of pertussis calls for re-evaluation of pertussis animal models

  2012cites this paper
• Immunity to the respiratory pathogen Bordetella pertussis

  2012cites this paper
• Live Metabolite-Deficient Bordetella pertussis: Determination of Suitability for use as a Vaccine in Humans using the Pertussis Mouse Model

  2012cites this paper
• Antigen-specific responses assessment for the evaluation of Bordetella pertussis T cell immunity in humans.

  2012cites this paper
• Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8+ T Cell Immune Response

  2011cites this paper
• The developing immune system and allergy

  2010cites this paper
• Development of improved vaccines against whooping cough: Current status

  2010cites this paper
• ong-term immunity against pertussis induced by a single nasal dministration of live attenuated B . pertussis BPZE 1 ascal

  2010cites this paper
• CHAPTER 6 – The Developing Immune System and Allergy

  2010cites this paper
• Humorale und zelluläre Immunität nach Pertussis- Auffrischimpfung im Jugendalter

  2010cites this paper
• Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.

  2010cites this paper
• Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

  2010cites this paper
• Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing.

  2009cites this paper
• Chapitre 19 – Acquisitions récentes en matière de vaccinations et vaccins du futur

  2009cites this paper
• IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.

  2009cites this paper
• A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells.

  2009cites this paper
• A Live Attenuated Bordetella pertussis Candidate Vaccine Does Not Cause Disseminating Infection in Gamma Interferon Receptor Knockout Mice

  2009cites this paper
• Cellular Immunity as a Potential Cause of Local Reactions to Booster Vaccination With Diphtheria and Tetanus Toxoids and Acellular Pertussis Antigens

  2009influential citation
• Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

  2008cites this paper
• Host genetics and genomics of Bordetella pertussis infection and vaccination.

  2008cites this paper
• Visiting Sick People: Is It Really Detrimental to Our Health?

  2008cites this paper
• Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice (cid:1)

  2007cites this paper
• Cellular Immunity in Adolescents and Adults following Acellular Pertussis Vaccine Administration

  2007cites this paper
• Toll-Like Receptor 4 Polymorphism Associated with the Response to Whole-Cell Pertussis Vaccination in Children from the KOALA Study

  2007cites this paper
• Potent CTL Induction by a Whole Cell Pertussis Vaccine in Anti‐Tumor Peptide Immunotherapy

  2007cites this paper
• Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice

  2007cites this paper
• Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine.

  2006cites this paper
• Relationship between maternal and child cytokine responses to allergen and phytohaemagglutinin 2 years after delivery

  2006cites this paper
• Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.

  2006cites this paper
• Interleukin-31: a new cytokine involved in inflammation of the skin.

  2006cites this paper
• Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen.

  2006cites this paper
• Dendritic Cell Immaturity during Infancy Restricts the Capacity To Express Vaccine-Specific T-Cell Memory

  2006cites this paper
• Ontogeny of the immune response

  2005cites this paper
• Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies

  2005cites this paper
• The effects of maternal smoking on infant immune development

  2005cites this paper
• A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine: Results of a Randomized, Controlled Trial

  2005cites this paper
• 60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune response.

  2005cites this paper
• Fish Oil Supplementation in Pregnancy Modifies Neonatal Progenitors at Birth in Infants at Risk of Atopy

  2005cites this paper
• Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

  2004cites this paper
• Toxicity and potency evaluation of pertussis vaccines

  2004cites this paper
• HLA-DR expression on neonatal monocytes is associated with allergen-specific immune responses.

  2004cites this paper
• Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.

  2004cites this paper
• Vacunas y embarazo (y II): la protección del recién nacido mediante la vacunación de la embarazada

  2004cites this paper
• Vacunas y embarazo (y II): la protección del recién nacido mediante la vacunación de la embarazada

  2004cites this paper
• Basic and clinical immunology HLA-DR expression on neonatal monocytes is associated with allergen-specific immune responses

  2004cites this paper
• [Vaccines and pregnancy (part 2): protection of the newborn by vaccinating pregnant women].

  2004cites this paper
• Part D - Pertussis

  2003cites this paper
• T-Cell Immune Response Assessment as a Complement to Serology and Intranasal Protection Assays in Determining the Protective Immunity Induced by Acellular Pertussis Vaccines in Mice

  2003cites this paper
• Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.

  2003cites this paper
• Maternal smoking in pregnancy alters neonatal cytokine responses

  2003cites this paper
• DISEASE STATES AND VACCINES: SELECTED CASES

  2003cites this paper
• Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.

  2002cites this paper
• Development of Interleukin-12-Producing Capacity throughout Childhood

  2002cites this paper
• Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses.

  2002cites this paper
• Les vaccins coquelucheux : composition, tolérance, immunogénicité et efficacité. Justifications du calendrier vaccinal en France

  2001cites this paper
• Immunity to Bordetella pertussis.

  2001cites this paper
• Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

  2001cites this paper
• Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function.

  2001cites this paper
• Recent progress in clinical and basic pertussis research

  2001cites this paper
• Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

  2001cites this paper
• Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines.

  2000cites this paper
• Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

  2000cites this paper
• Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients?

  2000cites this paper
• Are Only Antibody Levels Involved in the Protection against Pertussis in Acellular Pertussis Vaccine Recipients

  2000cites this paper
• Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.

  2000cites this paper